BSE Live
Nov 12, 16:01Prev. Close
103.95
Open Price
105.40
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 12, 15:47Prev. Close
104.57
Open Price
104.29
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Brooks Laboratories (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 24.70 | 16.19 | 16.19 | 16.19 | 16.19 | |
| Total Share Capital | 24.70 | 16.19 | 16.19 | 16.19 | 16.19 | |
| Reserves and Surplus | 73.71 | 83.41 | 98.29 | 112.09 | 105.86 | |
| Total Reserves and Surplus | 73.71 | 83.41 | 98.29 | 112.09 | 105.86 | |
| Total Shareholders Funds | 98.42 | 105.15 | 114.47 | 128.28 | 122.05 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 11.40 | 13.86 | 16.63 | 10.73 | 0.34 | |
| Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 1.46 | |
| Other Long Term Liabilities | 0.53 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 1.72 | 1.48 | 1.08 | 0.87 | 0.76 | |
| Total Non-Current Liabilities | 13.65 | 15.34 | 17.71 | 11.59 | 2.57 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 12.61 | 14.47 | 8.54 | 2.18 | 5.28 | |
| Trade Payables | 26.07 | 27.14 | 26.65 | 18.36 | 15.92 | |
| Other Current Liabilities | 6.56 | 5.64 | 4.95 | 3.60 | 5.41 | |
| Short Term Provisions | 0.56 | 0.22 | 0.35 | 0.13 | 1.31 | |
| Total Current Liabilities | 45.80 | 47.46 | 40.48 | 24.26 | 27.92 | |
| Total Capital And Liabilities | 157.86 | 167.95 | 172.67 | 164.13 | 152.54 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 112.85 | 117.17 | 124.01 | 125.31 | 16.34 | |
| Intangible Assets | 0.17 | 0.08 | 0.00 | 0.00 | 0.00 | |
| Capital Work-In-Progress | 0.00 | 0.00 | 0.52 | 0.00 | 87.09 | |
| Other Assets | 0.00 | 0.63 | 0.63 | 0.63 | 0.00 | |
| Fixed Assets | 113.13 | 118.17 | 125.17 | 125.95 | 103.42 | |
| Non-Current Investments | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Deferred Tax Assets [Net] | 0.00 | 10.91 | 10.74 | 6.99 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 16.56 | |
| Other Non-Current Assets | 6.79 | 6.88 | 6.05 | 9.30 | 0.00 | |
| Total Non-Current Assets | 119.95 | 135.99 | 141.97 | 142.26 | 120.01 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 13.77 | 10.05 | 11.41 | 7.70 | 6.69 | |
| Trade Receivables | 15.56 | 11.42 | 10.18 | 10.69 | 18.91 | |
| Cash And Cash Equivalents | 1.53 | 3.47 | 1.96 | 1.84 | 2.23 | |
| Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.02 | 4.48 | |
| OtherCurrentAssets | 7.05 | 7.02 | 7.14 | 1.62 | 0.22 | |
| Total Current Assets | 37.92 | 31.96 | 30.69 | 21.87 | 32.53 | |
| Total Assets | 157.86 | 167.95 | 172.67 | 164.13 | 152.54 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 25.77 | 25.90 | 24.77 | 20.38 | 35.25 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 2.94 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.64 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 9.12 | 9.12 | 9.12 | 9.12 | 9.12 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
12.06.2025
Brooks Labs Standalone March 2025 Net Sales at Rs 23.32 crore, up 31.57% Y-o-Y
05.06.2025
Brooks Labs Consolidated March 2025 Net Sales at Rs 23.32 crore, up 31.57% Y-o-Y
04.03.2025
Brooks Labs Consolidated December 2024 Net Sales at Rs 38.45 crore, up 76.8% Y-o-Y
18.11.2024
Brooks Labs Standalone September 2024 Net Sales at Rs 20.79 crore, down 14.49% Y-o-Y
12.06.2025
Brooks Labs Standalone March 2025 Net Sales at Rs 23.32 crore, up 31.57% Y-o-Y
05.06.2025
Brooks Labs Consolidated March 2025 Net Sales at Rs 23.32 crore, up 31.57% Y-o-Y
04.03.2025
Brooks Labs Consolidated December 2024 Net Sales at Rs 38.45 crore, up 76.8% Y-o-Y
18.11.2024
Brooks Labs Standalone September 2024 Net Sales at Rs 20.79 crore, down 14.49% Y-o-Y